Traditional Chinese medicine composition capable of promoting directed differentiation of stem cells into cardiomyocytes, traditional Chinese medicine effective component composition and application thereof

A technology of directional differentiation and cardiomyocytes, applied in the field of stem cells, can solve problems such as arrhythmia complications and unstable treatment effects, and achieve high purity and maturity, clear and complete myofimen and sarcomeres, and good reproducibility

Active Publication Date: 2022-06-24
TANGYI HLDG(SHENZHEN) LTD +1
View PDF3 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There is also evidence that iPS-induced cardiomyocytes do not fully possess the morphological and functional characteristics of mature cardiomyocytes, and potential arrhythmia complications and long-term unstable therapeutic effects after transplantation have become the main obstacles to clinical application.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Traditional Chinese medicine composition capable of promoting directed differentiation of stem cells into cardiomyocytes, traditional Chinese medicine effective component composition and application thereof
  • Traditional Chinese medicine composition capable of promoting directed differentiation of stem cells into cardiomyocytes, traditional Chinese medicine effective component composition and application thereof
  • Traditional Chinese medicine composition capable of promoting directed differentiation of stem cells into cardiomyocytes, traditional Chinese medicine effective component composition and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0040] The present invention will be further described in detail below with reference to the accompanying drawings, so that those skilled in the art can refer to the description and implement accordingly.

[0041] It should be understood that terms such as "having", "comprising" and "including" as used herein do not assign the presence or addition of one or more other elements or combinations thereof.

[0042] The present invention provides a traditional Chinese medicine compound with the effect of promoting the directional differentiation of stem cells to cardiomyocytes, including: sea dragon, velvet antler, hippocampus, ginseng, astragalus, epimedium, ziheche, salvia miltiorrhiza, gynostemma pentaphyllum and tianshan snow lotus.

[0043] In some of the embodiments of the present invention, preferably, in the traditional Chinese medicine complex, the quality of sea dragon, velvet antler, hippocampus, ginseng, astragalus, epimedium, ziheche, salvia, gynostemma pentaphyllum and ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a traditional Chinese medicine compound capable of promoting the directed differentiation of stem cells into cardiomyocytes, including: dragonfish, velvet antler, hippocampus, ginseng, astragalus, epimedium, purple river carnation, salvia miltiorrhiza, gynostemma pentaphyllum and Tianshan snow lotus. The invention discloses a traditional Chinese medicine active component composition capable of promoting the directional differentiation of cardiomyocytes from stem cells, including: icariin, astragaloside IV, ginsenoside Rg1, PLGF 2 , salvianolic acid B, sphingosine-1-phosphate, deer antler polypeptide, sea dragon extract and hippocampus extract. The present invention also discloses a compound capable of promoting the directional differentiation of stem cells into cardiomyocytes, which is a new isomer of the new compound-iridoid glycoside Scropolioside D from the mixture of velvet antler polypeptide, sea dragon extract and hippocampus extract . The invention also discloses their use in the preparation of drugs or kits for promoting the directional differentiation of stem cells into cardiomyocytes and in scientific research.

Description

technical field [0001] The present invention relates to the technical field of stem cells, in particular to traditional Chinese medicine complexes, effective component compositions of traditional Chinese medicines, compounds and applications thereof. Background technique [0002] The cardiology community has made great strides in drug development and surgical treatment in recent years, but heart failure remains the leading cause of death worldwide. Even with the rapid maturity and popularization of cardiac interventional technology, the unavoidable myocardial ischemia-reperfusion injury and irreversible myocardial necrosis after myocardial infarction still exist, which still affects the functional recovery of the heart to varying degrees. Especially for patients with end-stage heart failure who develop drug resistance to long-term drug therapy, the only treatment option is heart transplantation. However, many factors such as high transplantation costs, lack of heart donors, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): A61K31/7048A61K36/537C07H1/08C07H17/07A61P9/00A61K35/32A61K35/50A61K35/60
CPCA61K35/60A61K35/32A61K36/258A61K36/481A61K36/296A61K35/50A61K36/537A61K36/424A61K36/285A61K31/7048C07H17/07C07H1/08A61P9/00A61K2300/00
Inventor 徐安龙李红梅
Owner TANGYI HLDG(SHENZHEN) LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products